Day One Biopharmaceuticals Income Statement (2022-2025) | DAWN

1Y3Y5Y7Y10YAll
Download Data
Income Statement Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Revenue & cost
Revenue (Quarter) 0.01B0.09B0.03B0.03B0.03B0.04B0.05B
Operating items
Research & Development (Quarter) 0.02B0.02B0.02B0.03B0.03B0.03B0.03B0.04B0.04B0.09B0.03B0.06B0.04B0.04B0.03B0.04B
Selling, General & Administrative (Quarter) 0.01B0.01B0.02B0.02B0.02B0.02B0.02B0.02B0.03B0.03B0.03B0.03B0.03B0.03B0.03B0.03B
Other Operating Expenses (Quarter) 0.00B0.00B0.00B0.00B0.00B0.00B0.01B
Operating Expenses (Quarter) 0.03B0.04B0.04B0.04B0.05B0.05B0.05B0.06B0.07B0.12B0.06B0.09B0.07B0.07B0.06B0.08B
Operating Income (Quarter) -0.03B-0.04B-0.04B-0.04B-0.05B-0.05B-0.05B-0.06B-0.07B-0.11B0.03B-0.07B-0.04B-0.03B-0.02B-0.03B
EBIT (Quarter) -0.03B-0.04B-0.04B-0.04B-0.05B-0.05B-0.05B-0.06B-0.07B-0.11B0.03B-0.07B-0.04B-0.03B-0.02B-0.03B
Non-operating items
Non Operating Investment Income (Quarter) 0.11B
Interest & Investment Income (Quarter) 0.00B0.00B0.00B0.00B0.00B0.00B0.01B0.01B0.00B0.00B0.01B0.01B0.01B0.00B0.00B0.00B
Other Non Operating Income (Quarter) -0.00B0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B0.00B0.00B-0.00B-0.00B-0.00B0.00B
Non Operating Income (Quarter) -0.00B0.00B0.00B-0.00B0.00B-0.00B-0.01B0.00B0.11B0.00B0.13B0.01B-0.00B-0.00B0.00B
Net income details
EBT (Quarter) -0.03B-0.04B-0.04B-0.04B-0.04B-0.05B-0.05B-0.05B-0.06B-0.11B0.03B-0.06B-0.04B-0.03B-0.02B-0.02B
Tax Provisions (Quarter) 0.00B-0.00B0.01B0.00B
Profit After Tax (Quarter) -0.03B-0.04B-0.04B-142.08B-0.04B-0.05B-0.05B-188.78B-0.06B-0.00B0.04B-95.47B-0.04B-0.03B-0.02B-107.24B
Income from Non-Controlling Interests (Quarter) 0.14B0.05B0.05B0.05B0.06B0.00B-0.04B0.06B0.04B0.03B0.02B
Income from Continuing Operations (Quarter) -0.03B-0.04B-0.04B-0.04B-0.04B-0.05B-0.05B-0.05B-0.06B-0.11B0.04B-0.07B-0.04B-0.03B-0.02B-0.03B
Consolidated Net Income (Quarter) -0.03B-0.04B-0.04B-0.04B-0.04B-0.05B-0.05B-0.05B-0.06B-0.11B0.04B-0.07B-0.04B-0.03B-0.02B-0.03B
Income towards Parent Company (Quarter) -0.03B-0.04B-0.04B-0.04B-0.04B-0.05B-0.05B-0.05B-0.06B-0.11B0.04B-0.07B-0.04B-0.03B-0.02B-0.03B
Net Income towards Common Stockholders (Quarter) -0.03B-0.04B-0.04B-0.04B-0.04B-0.05B-0.05B-0.05B-0.06B-0.11B0.04B-0.07B-0.04B-0.03B-0.02B-0.03B
Additional items
EPS (Basic) (Quarter) -0.48-0.60-0.53-0.56-0.59-0.61-0.54-0.64-0.72-0.050.38-0.69-0.35-0.29-0.19-0.21
EPS (Weighted Average and Diluted) (Quarter) -0.48-0.60-0.53-0.56-0.59-0.61-0.54-0.64-0.72-0.050.38-0.69-0.35-0.29-0.19-0.21
Shares Outstanding (Weighted Average) (Quarter) 0.06B0.06B0.07B0.07B0.07B0.07B0.08B0.08B0.09B0.09B0.09B0.09B0.10B0.10B0.10B0.10B
Shares Outstanding (Diluted Average) (Quarter) 0.06B0.06B0.07B0.07B0.07B0.07B0.09B0.08B0.09B0.09B0.09B0.09B0.10B0.10B0.10B0.10B
EBITDA (Quarter) -0.03B-0.04B-0.04B-0.04B-0.05B-0.05B-0.05B-0.06B-0.07B-0.11B0.03B-0.07B-0.04B-0.03B-0.02B-0.03B
Tax Rate (Quarter) -1.40%-2.52%-10.85%-8.48%